UnitedHealth Stock (UNH) Gets Price Target Boost on Medicare Advantage Optimism
TD Cowen analyst Ryan Langston raised UnitedHealth's price target to $335 from $275, maintaining a Hold rating. The upgrade reflects confidence in the healthcare giant's margin recovery, particularly within its Medicare Advantage segment.
Langston highlights the 2027 MA Advance Notice as a positive signal, anticipating favorable rate adjustments due to higher cost trends. UnitedHealth is expected to regain full target margins in MA within two years.
Uncertainty lingers for 2026 amid potential disruptions from the v28 risk adjustment changes. Benefit reductions may protect margins but could strain member retention. Market watchers await clarity on whether new leadership will provide 2026 guidance.